Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
© 2016 Society for Adolescent Health and Medicine. All rights reserved. Purpose About a third of untreated, perinatally HIV-infected children reach adolescence. We evaluated the durability and effectiveness of non-nucleoside reverse-transcriptase inhibitor (NNRTI)-based antiretroviral therapy (ART)...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84955237815&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42010 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-42010 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-420102017-09-28T04:24:46Z Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia Boettiger D. Sudjaritruk T. Nallusamy R. Lumbiganon P. Rungmaitree S. Hansudewechakul R. Kumarasamy N. Bunupuradah T. Saphonn V. Truong K. Yusoff N. Do V. Nguyen L. Razali K. Fong S. Kurniati N. Kariminia A. © 2016 Society for Adolescent Health and Medicine. All rights reserved. Purpose About a third of untreated, perinatally HIV-infected children reach adolescence. We evaluated the durability and effectiveness of non-nucleoside reverse-transcriptase inhibitor (NNRTI)-based antiretroviral therapy (ART) in this population. Methods Data from perinatally HIV-infected, antiretroviral-naïve patients initiated on NNRTI-based ART aged 10-19 years who had ≥6 months of follow-up were analyzed. Competing risk regression was used to assess predictors of NNRTI substitution and clinical failure (World Health Organization Stage 3/4 event or death). Viral suppression was defined as a viral load < 400 copies/mL. Results Data from 534 adolescents met our inclusion criteria (56.2% female; median age at treatment initiation 11.8 years). After 5 years of treatment, median height-for-age z score increased from -2.3 to -1.6, and median CD4+ cell count increased from 131 to 580 cells/mm 3 . The proportion of patients with viral suppression after 6 months was 87.6% and remained > 80% up to 5 years of follow-up. NNRTI substitution and clinical failure occurred at rates of 4.9 and 1.4 events per 100 patient-years, respectively. Not using cotrimoxazole prophylaxis at ART initiation was associated with NNRTI substitution (hazard ratio [HR], 1.5 vs. using; 95% confidence interval [CI] = 1.0-2.2; p =.05). Baseline CD4+ count ≤200 cells/mm 3 (HR, 3.3 vs. > 200; 95% CI = 1.2-8.9; p =.02) and not using cotrimoxazole prophylaxis at ART initiation (HR, 2.1 vs. using; 95% CI = 1.0-4.6; p =.05) were both associated with clinical failure. Conclusions Despite late ART initiation, adolescents achieved good rates of catch-up growth, CD4+ count recovery, and virological suppression. Earlier ART initiation and routine cotrimoxazole prophylaxis in this population may help to reduce current rates of NNRTI substitution and clinical failure. 2017-09-28T04:24:46Z 2017-09-28T04:24:46Z 2016-04-01 Journal 1054139X 2-s2.0-84955237815 10.1016/j.jadohealth.2015.11.006 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84955237815&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42010 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
description |
© 2016 Society for Adolescent Health and Medicine. All rights reserved. Purpose About a third of untreated, perinatally HIV-infected children reach adolescence. We evaluated the durability and effectiveness of non-nucleoside reverse-transcriptase inhibitor (NNRTI)-based antiretroviral therapy (ART) in this population. Methods Data from perinatally HIV-infected, antiretroviral-naïve patients initiated on NNRTI-based ART aged 10-19 years who had ≥6 months of follow-up were analyzed. Competing risk regression was used to assess predictors of NNRTI substitution and clinical failure (World Health Organization Stage 3/4 event or death). Viral suppression was defined as a viral load < 400 copies/mL. Results Data from 534 adolescents met our inclusion criteria (56.2% female; median age at treatment initiation 11.8 years). After 5 years of treatment, median height-for-age z score increased from -2.3 to -1.6, and median CD4+ cell count increased from 131 to 580 cells/mm 3 . The proportion of patients with viral suppression after 6 months was 87.6% and remained > 80% up to 5 years of follow-up. NNRTI substitution and clinical failure occurred at rates of 4.9 and 1.4 events per 100 patient-years, respectively. Not using cotrimoxazole prophylaxis at ART initiation was associated with NNRTI substitution (hazard ratio [HR], 1.5 vs. using; 95% confidence interval [CI] = 1.0-2.2; p =.05). Baseline CD4+ count ≤200 cells/mm 3 (HR, 3.3 vs. > 200; 95% CI = 1.2-8.9; p =.02) and not using cotrimoxazole prophylaxis at ART initiation (HR, 2.1 vs. using; 95% CI = 1.0-4.6; p =.05) were both associated with clinical failure. Conclusions Despite late ART initiation, adolescents achieved good rates of catch-up growth, CD4+ count recovery, and virological suppression. Earlier ART initiation and routine cotrimoxazole prophylaxis in this population may help to reduce current rates of NNRTI substitution and clinical failure. |
format |
Journal |
author |
Boettiger D. Sudjaritruk T. Nallusamy R. Lumbiganon P. Rungmaitree S. Hansudewechakul R. Kumarasamy N. Bunupuradah T. Saphonn V. Truong K. Yusoff N. Do V. Nguyen L. Razali K. Fong S. Kurniati N. Kariminia A. |
spellingShingle |
Boettiger D. Sudjaritruk T. Nallusamy R. Lumbiganon P. Rungmaitree S. Hansudewechakul R. Kumarasamy N. Bunupuradah T. Saphonn V. Truong K. Yusoff N. Do V. Nguyen L. Razali K. Fong S. Kurniati N. Kariminia A. Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia |
author_facet |
Boettiger D. Sudjaritruk T. Nallusamy R. Lumbiganon P. Rungmaitree S. Hansudewechakul R. Kumarasamy N. Bunupuradah T. Saphonn V. Truong K. Yusoff N. Do V. Nguyen L. Razali K. Fong S. Kurniati N. Kariminia A. |
author_sort |
Boettiger D. |
title |
Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia |
title_short |
Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia |
title_full |
Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia |
title_fullStr |
Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia |
title_full_unstemmed |
Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia |
title_sort |
non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in perinatally hiv-infected, treatment-naïve adolescents in asia |
publishDate |
2017 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84955237815&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42010 |
_version_ |
1681422108522971136 |